Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sullivan

Showing results (1221-1230 of 1,317) with videos related to

Pageof 132
Sort By:
Nature|June 10, 2026
Lignin to adipic acid in a high-yield chemical and biological redox processKathryn M Mains, Chad T Palumbo, Davide Rigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
The New England Journal of Medicine|June 25, 2020
Effect on Patient Safety of a Resident Physician Schedule without 24-Hour ShiftsChristopher P Landrigan, Shadab A Rahman, Jason P Sullivan, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Molecular Psychiatry|October 19, 2005
Variants in Apaf-1 segregating with major depression promote apoptosome functionJ Harlan, Y Chen, E Gubbins, et al.
Pediatrics|February 23, 2021
Extended Work Shifts and Neurobehavioral Performance in Resident-PhysiciansShadab A Rahman, Jason P Sullivan, Laura K Barger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonistGerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Pain|January 13, 2009
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermiaPrisca Honore, Prasant Chandran, Gricelda Hernandez, et al.
Pediatric Quality & Safety|September 20, 2018
Optimizing a Nurse-led Transitional Home Visit Program in Preparation for a Randomized Control TrialHadley S Sauers-Ford, Heather Tubbs-Cooley, Angela M Statile, et al.
Nature Methods|December 12, 2019
Publisher Correction: Analysis of the Human Protein Atlas Image Classification competitionWei Ouyang, Casper F Winsnes, Martin Hjelmare, et al.
Pageof 132

Showing results (1221-1230 of 1,317) with videos related to

Sort By:
Pageof 132
Nature|June 10, 2026
Lignin to adipic acid in a high-yield chemical and biological redox processKathryn M Mains, Chad T Palumbo, Davide Rigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
The New England Journal of Medicine|June 25, 2020
Effect on Patient Safety of a Resident Physician Schedule without 24-Hour ShiftsChristopher P Landrigan, Shadab A Rahman, Jason P Sullivan, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Molecular Psychiatry|October 19, 2005
Variants in Apaf-1 segregating with major depression promote apoptosome functionJ Harlan, Y Chen, E Gubbins, et al.
Pediatrics|February 23, 2021
Extended Work Shifts and Neurobehavioral Performance in Resident-PhysiciansShadab A Rahman, Jason P Sullivan, Laura K Barger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonistGerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Pain|January 13, 2009
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermiaPrisca Honore, Prasant Chandran, Gricelda Hernandez, et al.
Pediatric Quality & Safety|September 20, 2018
Optimizing a Nurse-led Transitional Home Visit Program in Preparation for a Randomized Control TrialHadley S Sauers-Ford, Heather Tubbs-Cooley, Angela M Statile, et al.
Nature Methods|December 12, 2019
Publisher Correction: Analysis of the Human Protein Atlas Image Classification competitionWei Ouyang, Casper F Winsnes, Martin Hjelmare, et al.
Pageof 132